Oligonucleotide analogues incorporating 5-aza-cytosine therein

Details for Australian Patent Application No. 2006297375 (hide)

Owner Astex Pharmaceuticals, Inc.

Inventors Phiasivongsa, Pasit; Redkar, Sanjeev

Agent Davies Collison Cave

Pub. Number AU-B-2006297375

PCT Pub. Number WO2007/041071

Priority 11/241,799 29.09.05 US

Filing date 25 September 2006

Wipo publication date 12 April 2007

Acceptance publication date 7 June 2012

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

B01L 3/00 (2006.01) Containers or dishes for laboratory use, e.g. laboratory glassware

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/041071 Priority application(s): WO2007/041071

2 February 2012 Alteration of Name

  The name of the applicant has been altered to Astex Pharmaceuticals, Inc.

7 June 2012 Application Accepted

  Published as AU-B-2006297375

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006297390-MIMO beamforming-based single carrier frequency division multiple access system

2006297370-Method and apparatus for monitoring user game-playing behavior and reporting game play data in a gaming environment